Find a Trial

Trial Summary


Protocol No.CTO-R5458-ONC-1826
StatusOPEN TO ACCRUAL
Principal InvestigatorSuvannasankha, Attaya
ScopeNational
PhasePhase I/II
Age GroupAdult
TitleA Phase 1/2 FIH Study of REGN5458 (anti-BCMA x anti-CD3 Bispecific Antibody) in Patients with Relapsed or Refractory Multiple Myeloma
Applicable Disease SitesMultiple Myeloma
Participating InstitutionsIU Health North Hospital
    Indiana University (IU)
      Treatment TypeTreatment
      ContactPhone: (317) 278-5632
      Email: iutrials@iu.edu